The 2025 Expert Consensus on cardiac biomarkers strongly recommends using hs-cTn, often combined with BNP/NT-proBNP, for both preoperative risk assessment and postoperative surveillance (daily for 48-72 hours) in high-risk patients undergoing noncardiac surgery. ...